CD24 and myeloproliferative disorder: Consistent with unchanged CD24 expression in HSCs from MPN mice or patients (see supplemental Figure 2C-E), analysis of MPN mice chronically treated with CD24-blocking antibody did not affect overall hematopoietic chimerism (supplemental Figure 6N).